Journals / Ulusal Cerrahi Dergisi / 2015 / Cilt: 31 - Sayı: 3

Tek veya çift aşı uygulamasını takiben asplenik hastaların immun profili: Boylamasına kesitsel çalışma

Immune profile of asplenic patients following single or double vaccine administration: A longitudinal cross-sectional study

Pages
118–123
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Early postoperative death and late overwhelming infections did not occur.Conclusion: Our results are indicative of the resumption of the immune function following Pneumo-23 and Act-HIB administrations, instigated by the probable activation of B cells and adequate production of C3, C4, IgG, and IgM antibodies in remote lymphoid tissues.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Splenectomy poses a lifelong threat for the development of uncontrolled sepsis despite vaccination.
📊
Key Findings & Data:As it is impractical to measure the levels of each antibody against 23 most frequent bacterial serotypes, different surrogate markers of immune response should be identified.Material and Methods: Forty-eight patients with benign disorders were vaccinated with Pneumo-23 and Act-HIB before or at the day of surgery.
💡
Conclusion & Impact:Early postoperative death and late overwhelming infections did not occur.Conclusion: Our results are indicative of the resumption of the immune function following Pneumo-23 and Act-HIB administrations, instigated by the probable activation of B cells and adequate production of C3, C4, IgG, and IgM antibodies in remote lymphoid tissues.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objective: Splenectomy poses a lifelong threat for the development of uncontrolled sepsis despite vaccination. As it is impractical to measure the levels of each antibody against 23 most frequent bacterial serotypes, different surrogate markers of immune response should be identified.Material and Methods: Forty-eight patients with benign disorders were vaccinated with Pneumo-23 and Act-HIB before or at the day of surgery. The immunological response and opsonization capacity of the patients after splenectomy was analyzed through the quantitative measurement of IgG, IgM, C3, and C4 titers; flow-cytometric analysis of (CD3+) T-lymphocytes and (CD19+) B-lymphocytes; and isolation of CD27+ B cells by immunomagnetic positive selection. Blood samples were drawn at the sixth month and 5 and 7 years after surgery.Results: The mean follow-up period was 98.4 months. All the patients in this series had normal IgG, C3, C4 levels and a normal distribution of CD19+ B-cells and CD8+ T-cells in three follow-up periods. Moreover, C3 levels markedly improved to 133.5±37.3 mg/dL at 5 years and remained stable thereafter. CD19+ B-lymphocyte values have progressively improved to the normal range in 98% patients at 7 years. Further, low levels of CD27+ B-cell population (memory cells) was observed in only 12.5% patients at the last follow-up. Adequate seroconversion of IgG, IgM with normal C3, C4, and CD19+ B-cell levels were accomplished in almost all patients. Early postoperative death and late overwhelming infections did not occur.Conclusion: Our results are indicative of the resumption of the immune function following Pneumo-23 and Act-HIB administrations, instigated by the probable activation of B cells and adequate production of C3, C4, IgG, and IgM antibodies in remote lymphoid tissues.

Özet

Amaç: Aşı uygulamasına rağmen; splenektomi, ciddi sepsis gelişimi için yaşam boyu tehdit oluşturmaktadır. En sık karşılaşılan 23 bakteriyel serotipe karşı antikor düzeylerini ölçmek pratik olmadığından, bağışıklık yanıtı farklı göstergelerle belirlenmelidir.Gereç ve Yöntemler: Benign hastalığı olan kırk sekiz olgu ameliyat öncesi ya da gününde Pneumo-23 ve Act-HIB ile aşılandı. Splenektomi sonrası immünolojik yanıtın yeterliliği ve opsonizasyon kapasitesi; IgG, IgM, C3 ve C4 titrelerinin kantitatif ölçümü, (CD3 +) T-lenfositleri ile (CD19 +) B-lenfositlerin akış sitometrik analizi ve CD27 + B hücrelerinin immünomanyetik pozitif seçim metodlu izolasyonu ile değerlendirildi. Kan örnekleri, ameliyat sonrası altıncı ay ile 5 ve 7. yılda alındı.Bulgular: Ortalama takip süresi 98,4 aydı. Serimizdeki tüm hastalarda IgG, C3, C4 seviyeleri ile CD19 + B-hücreleri ile CD8 + T-hücrelerinin dağılımı, her üç dönemde de normaldi. Ayrıca; 5. yılda C3 düzeyleri 133,5±37,3 mg/dL yükseldi ve sonrasında sabit seyretti. CD19 + B-lenfosit değerleri giderek düzelip, 7 yılda hastaların %98'inde normal sınırlara ulaştı. Son takipte, düşük düzeyde CD27 + B-hücre popülasyonuna (bellek hücreleri) sahip hastaların oranı sadece %12,5 idi. Hastaların hemen tümünde normal C3, C4 ve CD19 (+) B-hücresi seviyeleri ile yeterli IgG, IgM serokonversiyonu sağlanmıştır. Ameliyat sonrası erken ölüm ve geç dönem şiddetli enfeksiyonlar oluşmamıştır.Sonuç: Sonuçlarımız, Pneumo-23 ve Act-HIB uygulamalarının ardından bağışıklık fonksiyonunun devamlılığını ve bunun olasılıkla uzak lenfoid dokularda B-hücre aktivasyonunun teşviki ve C3, C4 ile IgG, IgM antikorlarının yeterli üretimi ile gerçekleştiğini göstermektedir.

🔖

Cite This Article

DOĞAN, S. M., AYKAS, A., YÜCEL, E. Ş., OKUT, G., ŞİMŞEK, C., ÇAYHAN, K., ZENGEL, B., USLU, A. (2015). Tek veya çift aşı uygulamasını takiben asplenik hastaların immun profili: Boylamasına kesitsel çalışma. Ulusal Cerrahi Dergisi, Cilt: 31 - Sayı: 3, 118–123. https://ajindex.com/articles/325390

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Ruben FL, Hankins WA, Zeigler Z, Norden CW, Harrison A, Winke A, et al. Antibody responses to meningococcal polysac- charide vaccine in adults without a spleen. Am J Med 1984; 76: 115-121. [CrossRef] Schwartz SI. Role of splenectomy in hematologic disorders. World J Surg 1996; 20: 1159. [CrossRef] Evans DJK. Postsplenectomy sepsis ten years or more after opera- tion. J Clin Pathol 1985; 38: 309-311. [CrossRef] Bisharat N, Omari H, Lavi I, Raz R. Risk of infection and death among post- splenectomy patients. J Infect 2001; 43: 182-186. [CrossRef] Dawson AA, Jones PF, King DJ. Splenectomy in the management of hematological disease. Br J Surg 1987; 74: 353-357. [CrossRef] Rubins J, Alter M, Loch J, Janoff E. Determination of antibody re- sponses of elderly adults to all 23 capsular polysaccharides after pneumococcal vaccination. Infect Immun 1999; 67: 5979-5984.
  2. Farr BM, Johnston BL, Cobb DK, Fisch MJ, Germanson TP, Adal KA, et al. Preventing pneumococcal bacteremia in patients at risk. Re- sults of a matched case-control study. Arch Intern Med 1995; 155: 2336-2340. [CrossRef] Käyhty H, Åhman H, Rönnberg PR, Tillikainen R, Eskola J. Pneumo- coccal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and chil- dren. J Infect Dis 1995; 172: 1273-1278. [CrossRef] Sigurdardottir ST, Vidarsson G, Gudnason T, Kjartansson S, Kristins- son KG, Jonsson S, et al. Immune responses of infants vaccinated with serotype 6B pneumococcal polysaccharide conjugated with tetanus toxoid. Pediatr Infect Dis J 1997; 16: 667-674. [CrossRef] Romero-Steiner S, Libutti D, Pais LB, Dykes J, Anderson P, Whitin JC, et al. Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococ- cus pneumoniae using differentiated HL-60 cells. Clin Diagn Lab Immunol 1997; 4: 415-422.
  3. Nieminen T, Käyhty H, Virolainen A, Eskola J. Circulating antibody secreting cell response to parenteral pneumococcal vaccines as an indicator of a salivary IgA antibody response. Vaccine 1998; 16: 313-319. [CrossRef] Kruetzmann S, Rosado MM, Weber H, Germing U, Tournilhac O, Peter HH, et al. Human immunoglobulin M memory B- cells con- trolling Streptococcus pneumoniae infections are generated in the spleen. J Exp Med 2003; 197: 939-945. [CrossRef] Jockovich M, Mendenhall NP, Sombeck MD, Talbert JL, Copeland EM 3rd, Bland KI. Long-term complications of laparotomy in Hodgkin's disease. Ann Surg 1994; 219: 615-621. [Cros